The most disruptive product to hit the newly legal hemp industry might be one that will never be sold directly to consumers. GW Pharmaceuticals, a London-based biotech company, is awaiting a final decision from the U.S. Food and Drug Administration to produce the first cannabis-derived treatment to win approval as legal medicine. The decision on […]
Impending ruling on epilepsy drug has CBD industry on alert is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs